EGFR is the most frequently altered receptor tyrosine kinase (RTK) in glioblastoma, but amplification and activating mutation or fusions have been also reported in other RTKs, such as PDGFRA, MET, FGFR, and NTRK1 [2]. This evidence concerns the gene NTRK1 and glioblastoma.